association

Full identifier: http://purl.org/np/RAlMbRF28zz4RwDaPXAOxzVHJGUsd8gbQsbNWB05mXOWY#association

Assigned to 1 class:

Minted in Nanopublication

 RAlMbRF28z comment approve/disapprove edit as derived nanopublication create new with same template

This is the identifier for this whole nanopublication. http://purl.org/np/RAlMbRF28z... This nanopublication date and time when the nanopublication was created http://purl.org/dc/terms/created was created on (this is a literal) "2021-06-12T15:49:38.945+02:00" .
This is the identifier for this whole nanopublication. http://purl.org/np/RAlMbRF28z... This nanopublication links to the assertion template that was used to create this nanopublication https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate was created from the assertion template http://purl.org/np/RAManV5GZI... RAManV5GZI .
This is the identifier for this whole nanopublication. http://purl.org/np/RAlMbRF28z... This nanopublication links to the provenance template that was used to create this nanopublication https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate was created from the provenance template http://purl.org/np/RANwQa4ICW... RANwQa4ICW .
This is the identifier for this whole nanopublication. http://purl.org/np/RAlMbRF28z... This nanopublication links to the publication info template that was used to create this nanopublication https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate was created from the publication info template http://purl.org/np/RAA2MfqdBC... RAA2MfqdBC .

References

Nanopublication Part Subject Predicate Object Published By Published On
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Leoni Bücken
2021-06-12T13:49:38.945Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
nexavar is a kinase inhibitor indicated for the treatment of 1 1 1 2 1 3 nexavar r nexavar is indicated for the treatment of patients with advanced renal cell carcinoma rcc nexavar is indicated for the treatment of patients with locally recurrent or metastatic progressive differentiated thyroid carcinoma dtc that is refractory to radioactive iodine treatment
Leoni Bücken
2021-06-12T13:49:38.945Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Leoni Bücken
2021-06-12T13:49:38.945Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Leoni Bücken
2021-06-12T13:49:38.945Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Leoni Bücken
2021-06-12T13:49:38.945Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Leoni Bücken
2021-06-12T13:49:38.945Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Leoni Bücken
2021-06-12T13:49:38.945Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Leoni Bücken
2021-06-12T13:49:38.945Z

Raw

TriG(txt), JSON-LD(txt), N-Quads(txt), XML(txt)